0000950123-21-014993.txt : 20211112 0000950123-21-014993.hdr.sgml : 20211112 20211112164333 ACCESSION NUMBER: 0000950123-21-014993 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ponoi II Management, LLC CENTRAL INDEX KEY: 0001746488 IRS NUMBER: 824521397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19918 FILM NUMBER: 211404343 BUSINESS ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001746488 XXXXXXXX 09-30-2021 09-30-2021 false Ponoi II Management, LLC

1 Letterman Drive Building D, Suite M-900 San Francisco CA 94129

13F HOLDINGS REPORT 028-19918 Y Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412) James Evangelista (415) 865-2050 /s/ James Evangelista San Francisco CA 11-12-2021 0 4 67488 false INFORMATION TABLE 2 7287.xml INFORMATION TABLE FOR FORM 13F Revolution Medicines Inc COM 76155X100 18845 685011 SH SOLE 685011 0 0 RAPT Therapeutics Inc COM 75382E109 4515 145401 SH SOLE 145401 0 0 NGM Biopharmaceuticals Inc COM 62921N105 27303 1298908 SH SOLE 1298908 0 0 Nurix Therapeutics Inc COM 67080M103 16825 561574 SH SOLE 561574 0 0